Aaron Lisberg

IDO Immune Status after Chemoradiation May Predict Survival in Lung Cancer Patients

A RASSF1A-HIF1α loop drives Warburg effect in cancer and pulmonary hypertension

Combining Immune Checkpoint Inhibitors With Conventional Cancer Therapy

Merkel cell carcinoma

The biology and treatment of Merkel cell carcinoma: current understanding and research priorities

Inflammation and tumor progression: signaling pathways and targeted intervention

Updates on the Systemic Treatment of Advanced Non-melanoma Skin Cancer

The Warburg effect: molecular aspects and therapeutic possibilities

Abscopal effect of radiotherapy combined with immune checkpoint inhibitors

Crosstalk in NF-κB signaling pathways

Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond

IKKα Shields 14-3-3σ, a G2/M Cell Cycle Checkpoint Gene, from Hypermethylation, Preventing Its Silencing

Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Lipid Nanoparticles Delivering Constitutively Active STING mRNA to Stimulate Antitumor Immunity

Implications of Adnexal Invasions in Primary Extramammary Paget’s Disease: A Systematic Review

CD8+ and Regulatory T cells Differentiate Tumor Immune Phenotypes and Predict Survival in Locally Advanced Head and Neck Cancer

Consolidative Radiotherapy for Limited Metastatic Non–Small-Cell Lung Cancer

Hyper-Progressive Disease: The Potential Role and Consequences of T-Regulatory Cells Foiling Anti-PD-1 Cancer Immunotherapy

Tumor Characteristics Associated with Benefit from Pembrolizumab in Advanced Non–Small Cell Lung Cancer

Previous radiotherapy and the clinical activity and toxicity of pembrolizumab in the treatment of non-small-cell lung cancer: a secondary analysis of the KEYNOTE-001 phase 1 trial

Viral oncoprotein antibodies as a marker for recurrence of Merkel cell carcinoma: A prospective validation study

Epigenetic Regulation of the Cell Type-Specific Gene 14-3-3σ